A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2006
10/11/2006	EP1709957A2 Sustained-release analgesic compounds
10/11/2006	EP1709012A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose)polymerase inhibitors
10/11/2006	EP1708709A1 METHODS OF TREATING ACUTE INFLAMMATION IN ANIMALS WITH p38 MAP KINASE INHIBITORS
10/11/2006	EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists
10/11/2006	EP1529041B1 Novel prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridil-n-2-hydroxycarbonylethyl)-amide, production and use thereof as medicaments
10/11/2006	EP1469851B1 Melanocortin receptor agonists
10/11/2006	EP1430045B1 Pyrane derivatives as both ace- and nep-inhibitors
10/11/2006	EP1363509B1 Compositions containing creatine and creatinine
10/11/2006	EP1299091B1 Matrix controlled transdermal system for stabile derivatives of ace inhibitors
10/11/2006	EP1257573B1 New transcription factor carp-2
10/11/2006	EP1250600B1 Diagnosis of tauopathies determining tau/phospho-tau ratio
10/11/2006	EP1216232B1 Heterocyclic compounds and methods for modulating cxcr3 function
10/11/2006	EP1173476B1 Soybean protein nutraceuticals
10/11/2006	EP1133311B1 INFLUENCING ANGIOGENESIS USING CD66a
10/11/2006	EP1107959B1 Quinazoline derivatives as medicaments
10/11/2006	EP1071792B1 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/11/2006	EP1049465B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/11/2006	EP0954565B1 Adipogenic differentiation of human mesenchymal stem cells
10/11/2006	EP0944619B1 Novel integrin receptor antagonists
10/11/2006	EP0896586B1 ErbB3 ANTIBODIES
10/11/2006	EP0832225B1 Chimeric proteins for use in transport of a selected substance into cells
10/11/2006	EP0804479B1 Method of treating diabetes mellitus using kgf
10/11/2006	EP0760672B1 Angiotensin ii for improving fertilization
10/11/2006	CN1846456A Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone
10/11/2006	CN1845911A Condensed ring compound and use thereof
10/11/2006	CN1845733A Tgf-beta gene expression inhibitor
10/11/2006	CN1843508A A composition for treating gastrointestinal distress
10/11/2006	CN1843498A Formula for dredging vein and dispelling cold and its preparation method
10/11/2006	CN1843410A Novel snuff aerosol
10/11/2006	CN1843390A Method for preparing yang-strengthening fatigue-relieving liquor containing micron pine pollen, deer antler and bone, tendon powder, cattle and donkey penis powder etc.
10/11/2006	CN1843389A Method for preparing yang-strengthening fatigue-relieving boil-free oral liquid containing micron pine pollen, deer antler and bone, tendon powder, cattle and donkey penis powder etc.
10/11/2006	CN1843388A Method for preparing yang-strengthening fatigue-relieving oral liquid containing micron pine pollen, deer antler and bone, tendon powder, cattle and donkey penis powder etc.
10/11/2006	CN1843387A Method for preparing yang-strengthening fatigue-relieving tablet containing micron pine pollen, deer antler and bone, tendon powder, cattle and donkey penis powder etc.
10/11/2006	CN1843386A Method for preparing yang-strengthening fatigue-relieving granula, capsule containing micron pine pollen, deer antler and bone, tendon powder, cattle and donkey penis powder etc.
10/11/2006	CN1843226A Age-resistant healthcare drink and its preparation method
10/11/2006	CN1843224A Preparation method for gastrodia elata cephalocathartic sport drink
10/11/2006	CN1843210A Giant salamander cooking method
10/11/2006	CN1279054C Type I cytokine receptor TCCR
10/11/2006	CN1279053C Modulators for beta-amyloid peptide aggregation comprising D-amino acids
10/11/2006	CN1279044C Non-steroidal progesterone receptor modulators
10/11/2006	CN1279041C Diazabicyclo alkane derivatives with NK1 antagonistic activity
10/11/2006	CN1279040C Tryasolyl tropane derivatives for therapy
10/11/2006	CN1279034C Dna－pk抑制剂 Dna-pk inhibitors
10/11/2006	CN1279023C Indole-3-sulphur derivatives
10/11/2006	CN1279014C Vitamin A analogue derivative with antiangiogenic, antitumoral and proapoptotic activities
10/11/2006	CN1278722C Orally disintegrating tablet of 'Baibaodan' and its preparation method
10/11/2006	CN1278716C Prepared Chinese medicine for anti fatigue and increasing body energy
10/11/2006	CN1278713C Snore-eliminating health tea
10/11/2006	CN1278689C Use of brassinolide in preparing medicine for reversing multiple medicine resistance of tumour cell
10/11/2006	CN1278683C Use of dipeptidyl peptidase IV inhibitor in preparing medicine for treating anxiety neurosis
10/10/2006	US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006	US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/10/2006	US7119170 Administering a polypeptide; blood disorders
10/10/2006	US7119165 Nogo receptor-mediated blockade of axonal growth
10/10/2006	US7119122 Compounds for the inhibition of nitric oxide synthase
10/10/2006	US7119119 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
10/10/2006	US7119118 90-95% eicosapentaenoic acid (EPA) and < 5% of docosahexaenoic acid (DHA); treating psychiatric or central nervous disorders
10/10/2006	US7119117 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/10/2006	US7119115 For therapy of treating tumors or cancerous cells
10/10/2006	US7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
10/10/2006	US7119109 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/10/2006	US7119107 Pyridone derivatives
10/10/2006	US7119103 β3-Adrenoreceptor agonists, agonist compositions and methods of using
10/10/2006	US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases
10/10/2006	US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors
10/10/2006	US7119087 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
10/10/2006	US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis
10/10/2006	US7119085 Inhibit amyloid protein deposits
10/10/2006	US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
10/10/2006	US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
10/10/2006	US7119080 Boronic ester and acid compounds, synthesis and uses
10/10/2006	US7119074 Treatment of cancers, tumors and malignancies using amphiphilic prodrugs
10/10/2006	US7119066 Replacing cysteine 17 with alanine, glutamine 63 with arginine and a deletion of the terminal 15 amino acid residues; treatment of huntington's disease, obesity, and gestational or adult onset diabetes
10/10/2006	US7118902 modified aggrecanases, nucleotides encoding such enzymes, and processes for producing these enzymes with improved stability; treatment of osteoarthritis
10/10/2006	US7118888 Gene expression vaccine
10/10/2006	US7118767 Pharmaceutical composition for increasing the production of nitric oxide and IFN-γ, and process for preparation thereof
10/10/2006	US7118748 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
10/10/2006	CA2418778C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/10/2006	CA2352554C Substituted benzimidazoles and their use as parp inhibitors
10/10/2006	CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
10/10/2006	CA2336000C N-substituted piperazines and 1,4-disubstituted piperidines
10/10/2006	CA2291233C Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
10/10/2006	CA2280730C Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
10/10/2006	CA2238277C Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
10/10/2006	CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
10/10/2006	CA2223594C Myogenic differentiation of human mesenchymal stem cells
10/10/2006	CA2196640C Substituted quinazoline derivatives
10/05/2006	WO2006105062A2 Altered antibody fc regions and uses thereof
10/05/2006	WO2006104989A2 Altered antibody fc regions and uses thereof
10/05/2006	WO2006104280A1 Prophylactic/therapeutic agent for diabetes
10/05/2006	WO2006104190A1 Par-2 agonist
10/05/2006	WO2006104172A1 Preventive and/or therapeutic agent for rheumatoid arthritis
10/05/2006	WO2006104161A1 THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-Met AUTOPHOSPHORYLATION INHIBITING POTENCY
10/05/2006	WO2006104154A1 Composition for enhancing expression and activity of protease in liver
10/05/2006	WO2006104137A1 Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same
10/05/2006	WO2006104136A1 Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver disease
10/05/2006	WO2006104030A1 Thiazole compound
10/05/2006	WO2006104008A1 Urea derivative, medicinal composition containing the same, and medicinal use of these
10/05/2006	WO2006055747A3 Bis(thio-hydrazide amides) for increasing hsp70 expression
10/05/2006	WO2006047372A9 Lamotrigine analogs

1 ... 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 ... 1564